Explores the benefits, risks, and growing acceptance of modern psychedelic therapy
Explores the benefits, risks, and growing acceptance of modern psychedelic therapy
Explores the benefits, risks, and growing acceptance of modern psychedelic therapy
• Examines the contemporary psychedelic phenomenon, including the history of criminalization and legalization, psychedelics’ effects on the brain, recent clinical research, and new therapeutic potentials
• Explores substances like psilocybin, LSD, DMT, ayahuasca, ketamine, and MDMA, including scientific evidence for psychedelics’ potential to treat addiction, depression, anxiety, trauma, and neurodegenerative diseases
• Includes extensive practical information on safety, risk, and harm reduction for both laypeople and mental health practitioners
Presenting a comprehensive guide to the exciting new landscape around psychedelics, psychopharmacologist Anton Gomez-Escolar examines the long history of criminalizing and (slowly) legalizing these substances and their increasingly demonstrable positive effects on body, mind, and spirit.
Exploring psilocybin, LSD, DMT, ayahuasca, ketamine, MDMA, and other substances, Gomez-Escolar looks at the multitude of scientific studies providing critical evidence for psychedelics’ ability to treat addiction, depression, anxiety, and trauma as well as their potential to treat neurodegenerative diseases such as Alzheimer’s. He provides key information for therapists and other health practitioners as well as explores the potential benefits and limitations of microdosing and how psychedelics could help with various neurological and mental health issues, including those related to the COVID-19 pandemic. Breaking down substances by type, the author looks at the main risks of each psychedelic and its benefits, best harm-reduction strategies, and the neural pathways each affects. Gomez-Escolar also includes a large selection of resources for people seeking to engage personally with psychedelics for healing.
“A well-researched, up-to-date summary of what’s on the cutting edge of the psychedelic renaissance, covering the latest neuroscience, clinical trials, and therapeutic potential of psychedelic medicines. The Psychedelic Reawakening is a crash course in psychoactive drugs, a wonderful overview of some of the most promising and powerful tools for treating mental health, and a valuable guide to learning harm reduction strategies. After so many years of psychedelics being criminalized, demonized, ridiculed, or ignored, Anton Gomez-Escolar’s The Psychedelic Reawakening is a breath of fresh air!” David Jay Brown, author of The Illustrated Field Guide to DMT Entities and The New Science of Psyche
“Gomez-Escolar expands our view of the vast potential of psychedelics for therapeutic use. He emphasizes that the use of such substances requires purposeful intention through set and setting to maximize benefits and promote safe use. The Psychedelic Reawakening is an excellent resource for therapists and other health professionals and their clients, policy makers, recreational users, psychonauts, and the general public.” Wade Richardson, author of The Psychedelic Mindmeld
“The Psychedelic Reawakening is relevant and necessary at a time when psychedelic drugs are already available for use in psychiatry, as is the case with ketamine, and as the available arsenal will grow over time: psilocybin, MDMA, DMT, and more. This book fills a necessary gap in this new medical and social panorama. In addition, Anton Gomez-Escolar is one of the best specialists in this field in Spain. The Psychedelic Reawakening will also serve to provide the media with objective and accessible information on a subject that, although still unknown, will be the future of mental health treatment, at a time when it is more necessary than ever.” José Carlos Bouso, Ph.D., scientific director of the International Center for Ethnobotanical Ed
“The Psychedelic Reawakening explores the resurgence of psychedelics and their potential in therapeutic settings. Written for both lay readers and mental health professionals, the book covers key psychedelics and provides an in-depth look at how these substances can address issues such as depression, anxiety, trauma, and neurodegenerative diseases. Gomez-Escolar also offers insights into the history of psychedelics’ criminalization and recent steps toward legalization. In addition, the book includes practical advice on harm reduction, safety, and microdosing, making it a comprehensive guide for those interested in the modern psychedelic renaissance and its impact on mental health and well-being.” Dr. Richard Louis Miller, M.A., Ph.D., author of Psychedelic Medicine at the End of Life
Anton Gomez-Escolar, MSc, MPH, MIR, is a psychopharmacologist who works on psychedelic research, drug education, and harm reduction. He is the founder of Drogopedia, has worked at organizations like Energy Control and the European Union Drugs Agency (EUDA), and has presented on psychedelics at several international forums, including the European Parliament and the United Nations. He is a member of the UNAD Global Drug Policy Commission, and cofounder and board member of the Spanish Society of Psychedelic Medicine (SEMPsi), the INAWE Foundation (for psychedelic science), and the Psychedelic Society of Madrid. He lives in Madrid.
This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.